Email Updates

Search form

You are here

Webinar & Meeting Reports

  • August 14, 2014

    The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO) invites you to join us for a webinar entitled “Do we need a new paradigm for HIV vaccine development?” with Dr. José Esparza who will give participants a greater understanding of some of the lessons learned after 30 years of HIV vaccine development.

  • July 20, 2014 to July 25, 2014

    The International AIDS Conference, or AIDS 2014, is a biennial gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.

  • July 17, 2014

    Rectal microbicide development has made strides in recent years, but, as with vaginal microbicides, adherence remains a concern for product developers.

    There are two "P" words we have always loved - pleasure and prevention.

  • July 1, 2014

    This webinar provided an overview of the AVAC Advocacy Fellowship and the 2015 application process for aspiring candidates. The Fellowship team at AVAC was joined by current and alumni Fellows to answer questions and discuss their experiences. For more information, visit the Fellowship application page.

  • June 30, 2014

    The US Women & PrEP Working Group, SisterLove and AVAC hosted a webinar marking the two-year anniversary of the FDA licensing of Truvada as PrEP in the US. 

  • June 4, 2014

    Why should you care if sexual lubricants are safe or not? What do we know, and what do we need to know? What’s happening to move the issue of lube safety forward? What’s not happening? Join IRMA and AVAC and our expert guests who will provide an exciting update on the latest in lubricant safety and help us answer these important questions.

  • May 20, 2014

    On May 14, the US Centers for Disease Control (CDC) and the US Public Health Service released new clinical guidelines on using daily oral TDF/FTC (also known as Truvada) as PrEP for HIV prevention. This type of guideline is used by the US government to set national norms for health providers. It is the first such national guideline issued anywhere for PrEP use. Representatives from the CDC provided an overview of the guidelines and answer questions about their content and implications. This was followed by a moderated discussion.

  • May 19, 2014

    This webinar, which coincided with observances of HIV Vaccine Awareness Day (May 18th) provided an update on follow-on trials that build on the positive findings from the RV144 Thai trial; what looks hopeful in early clinical and pre-clinical science; and why the field has increasing optimism about finding effective HIV-specific antibodies, the "holy grail" of anti-HIV immune responses. As always, your comments and questions help guide the discussion.

  • May 6, 2014

    A webinar in memory of HIV prevention pioneer and revolutionary Jeff McConnell. A respected and passionate sociologist, Jeff (who passed away at the age of 49 this past February) was also a gay man living with HIV, and his identity was an important component of the science he conducted. His brilliant, human-touch research on gay men’s sex, sexuality, and various prevention methodologies involving treatment and PrEP was groundbreaking, visionary, and way ahead of most of us.

  • April 28, 2014

    The fourth webinar in AVAC's Research & Reality series, a year-long dialogue about prevention research and advocacy, this call provided a forum to learn about and discuss key issues around women and the HIV prevention agenda, including challenges around marketing of and adherence to new prevention options.

Pages